Results for tag: "Pre Diabetes Drug"

The Pre Diabetes Drug market is a subset of the Endocrine and Metabolic Disorders Drugs market. These drugs are used to treat pre-diabetes, a condition in which blood sugar levels are higher than normal but not high enough to be classified as diabetes. Pre-diabetes is a risk factor for developing type 2 diabetes, and these drugs are used to help prevent the onset of diabetes. Commonly prescribed pre-diabetes drugs include metformin, acarbose, and glimepiride. These drugs work by increasing insulin sensitivity, reducing glucose production in the liver, and slowing the absorption of glucose from the intestines. Some companies in the Pre Diabetes Drug market include Novo Nordisk, Sanofi, Merck, and Eli Lilly. Show Less Read more